BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BEBRF - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://blepharospasm.org
X-WR-CALDESC:Events for BEBRF
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211101
DTEND;VALUE=DATE:20220201
DTSTAMP:20211101T135634Z
CREATED:20211101T135522Z
LAST-MODIFIED:20211101T135634Z
UID:2798-1635724800-1643673599@blepharospasm.org
SUMMARY:Participate in a Clinical Trial!
DESCRIPTION:The drug company ADDEX together with Dr. Buz Jinnah of Emory University (who serves on our MAB and the Medical and Scientific Advisory Council for DMRF) is launching a trial of a new class of medications known as allosteric modulators. The name of the drug they will use is dipraglurant. It is being studied for possible use with Parkinson’s disease and dystonias. \nThe study will be a small pilot trial of about 15 patients. The patients will take oral medication and then stay at Emory University for several hours of observation\, followed by a second dose. The next day\, a third dose will be given. So\, participation would require 2 days at Emory University in Atlanta. \nIf you are interested in participating in this research\, please contact Cameron Injoo for further information: cameron.injoo.yeo@emory.edu
URL:https://blepharospasm.org/event/participate-in-research/
END:VEVENT
END:VCALENDAR